• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/11

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

11 Cards in this Set

  • Front
  • Back
Classification
Vasodilator, nitrate, antianginal
Mechanism of action
1. Relaxes smooth muscles causing venous dilation
2. Reduces preload and afterload to the heart
3. Dilates the coronary arteries resulting in increased perfusion of the myocardium
Indications
1. Chest pain cardiac origin
2. Acute pulmonary Edema
Contraindications
1. Blood pressure less than 90 mmHg systolic
2. Patients who have taken Erectile Dysfunction (PDE5 Inhibitors) medications in the last 24-48 hours
3. Signs and systems of head trauma (increasers intracranial pressure) or cerebral hemorrhage
4. Poor systemic perfusion
Side Effects
CARDIOVASCULAR: Hypotension, bradycardia, rebound hypertension/ tachycardia, palpations
NEUROLOGICAL: headache
OTHER: Flushed skin, sublingual burning
Precautions
Monitor blood pressure closely for signs of hypotension (Before and after administration)
Interactions
Use with caution with patients who already use vasodilators, alcohol, calcium channel blockers, beta blockers and phenothiazides
Routes or Administration
SL, TM (Transmucosal), Transdermal (nitropaste)
Onset and duration of Actions
Onset in 1-3 minutes and may last 30-60 minutes
Dosages
ADULT: 0.4 mg as a single spray or single tablet. May repeat every 3-5 minutes Nitropaste in 15 mg per one inch, doses are protocol dependent
PEDIATRIC: Not Recommended
Notes
1. Do not shake canister if administered as a spray as it will altered the metered dose in a single spray
2. Do not have patient inhale drug on administration as it will alter absorption rate
3. Establish IV prior to or immediately following administration to combat hypotension if necessary